All news

HCA clinical chief sells $593,582 in company stock

Alpha Vantage · Investing.com · · AI-summarised by FinFlash

HCA Healthcare EVP and Chief Clinical Officer Michael J. Schlosser sold 1,200 shares for $593,582. The sale follows strong Q3 2026 results that beat Wall Street expectations, though future earnings are projected to stay consistent with 2026. HCA trades at a low P/E relative to near-term earnings growth and screens as undervalued.

Read original source

HCA company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.